Holen Sie sich die Stockscreener-App
406.59
0.59%
-2.42
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$409.01
Offen:
$411.38
24-Stunden-Volumen:
1.65M
Relative Volume:
1.15
Marktkapitalisierung:
$90.20B
Einnahmen:
$76.39B
Nettoeinkommen (Verlust:
$7.81B
KGV:
13.98
EPS:
29.0772
Netto-Cashflow:
$7.93B
1W Leistung:
-0.95%
1M Leistung:
+8.91%
6M Leistung:
-13.87%
1J Leistung:
+7.47%
1-Tages-Spanne:
$400.19
$414.18
1-Wochen-Bereich:
$400.19
$429.54
52-Wochen-Spanne:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
406.59 | 90.20B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
204.25 | 17.59B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
232.80 | 14.94B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.02 | 12.90B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
110.16 | 10.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
HCA Healthcare stock holds steady as hospital operator focuses on patient volumes and cost control - ad-hoc-news.de
HCA Florida Palms West Hospital Tops Off Expansion In Loxahatchee, Florida - Healthcare Design Magazine
HCA stock reflects steady US hospital demand as investors weigh long-term healthcare trends - ad-hoc-news.de
Enterprise value to EBIT forward of HCA Healthcare Inc – XETR:2BH - TradingView
HCA Healthcare stock reflects a major US hospital operator navigating long-term demand - ad-hoc-news.de
HCA Healthcare, Inc. $HCA Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
HCA Healthcare stock steadies as investors weigh hospital demand and expansion plans - ad-hoc-news.de
Stephens Adjusts Price Target on HCA Healthcare to $500 From $530 - marketscreener.com
Isthmus Partners LLC Sells 3,454 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare, Inc. (NYSE:HCA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
The Premium On HCA Healthcare Keeps Growing. So Does The Case For Universal Health - Trefis
HCA Healthcare (HCA) Could Be 35% Undervalued Following Downgrades And Index Exits - Yahoo Finance
HCA Healthcare Stock And 2 More Names Facing The Next US Immigration Test - simplywall.st
HCA Healthcare (HCA) Publishes Gene Editing Research For Children With Severe Blood Disorders - Yahoo Finance
HCA Healthcare (NYSE:HCA) Expansion Draws Healthcare Market Attention - Kalkine Media
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
HCA Healthcare Shares Fall After Barclays Downgrade - marketscreener.com
Is the Options Market Predicting a Spike in HCA Healthcare Stock? - Zacks Investment Research
HCA FLORIDA PALMS WEST HOSPITAL CELEBRATES TOPPING OUT MILESTONE FOR MAJOR HOSPITAL EXPANSION - Florida Hospital News and Healthcare Report
BofA Securities Adjusts HCA Healthcare Price Target to $435 From $415 - Moomoo
HCA Healthcare (HCA): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Barclays Downgrades HCA Healthcare to Equal Weight From Overweight, Adjusts PT to $427 From $496 - marketscreener.com
Steve Young named chief executive officer of HCA Florida Brandon Hospital - Florida Hospital News and Healthcare Report
HCA Florida Northside Hospital welcomes Brent Burish as chief executive officer - Florida Hospital News and Healthcare Report
Barclays downgrades HCA Healthcare stock rating on volume uncertainty - Investing.com
BofA Securities Upgrades HCA Healthcare(HCA.US) to Buy Rating, Raises Target Price to $435 - Moomoo
Swedbank AB Sells 5,716 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare's Fall Shouldn't Be Construed As Failing Health - Seeking Alpha
Is HCA (HCA) Using Index Removal To Quietly Redefine Its Growth and Capital Allocation Playbook? - simplywall.st
CapEx per share of HCA Healthcare Inc – LS:A1JFMW - TradingView
Understanding the Setup: (HCA) and Scalable Risk - Stock Traders Daily
HCA’s North Florida Hospital to end professional chaplain services - Mainstreet Daily News Gainesville
HCA Healthcare Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Can HCA's Capacity Expansion Strategy Fuel Its Long-Term Growth? - Yahoo Finance
HCA Maintained by Cantor Fitzgerald -- Price Target Lowered to $525 - GuruFocus
Ascension outbids HCA, Optum for Williamson Health - Modern Healthcare
Cantor Fitzgerald lowers HCA Healthcare price target to $528 on setup - Investing.com
HCA Healthcare explores long-term growth. US hospital operator focuses on operations and patient vol - AD HOC NEWS
How HCA Healthcare’s (HCA) Advanced Therapy Research Highlights Its High-Acuity Care Capabilities - Yahoo Finance
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
HCA West Florida names new CEOs for Northside, Brandon hospitals - The Business Journals
If EPS Growth Is Important To You, HCA Healthcare (NYSE:HCA) Presents An Opportunity - Moomoo
HCA Healthcare, Inc. (HCA) Stock Analysis: A Robust 21.87% Upside Potential Awaits Investors - DirectorsTalk Interviews
HCA Healthcare Inc Actuals & Estimates (NYSE:HCA) - TradingView
Fideuram Intesa Sanpaolo Private Banking S.P.A. Trims Stock Position in HCA Healthcare, Inc. $HCA - MarketBeat
Elevation Point Wealth Partners LLC Has $10.03 Million Stock Position in HCA Healthcare, Inc. $HCA - MarketBeat
A Look at HCA Healthcare Inc (HCA) After 4.4% Gain -- GF Value $452.20 vs Price $410.50 - GuruFocus
HCA Healthcare Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
HCA Healthcare Jumps 5.2% Amid Sector-Wide Rally - AlphaStreet
HCA Healthcare Foundation awards grants to 89 Middle Tennessee nonprofits, advancing community health - HCA Healthcare Today
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.22%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):